These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34145687)

  • 21. Whole-body muscle MRI of patients with MATR3-associated distal myopathy reveals a distinct pattern of muscular involvement and highlights the value of whole-body examination.
    Mensch A; Kraya T; Koester F; Müller T; Stoevesandt D; Zierz S
    J Neurol; 2020 Aug; 267(8):2408-2420. PubMed ID: 32361838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Muscle MRI in Duchenne muscular dystrophy: Evidence of a distinctive pattern.
    Polavarapu K; Manjunath M; Preethish-Kumar V; Sekar D; Vengalil S; Thomas P; Sathyaprabha TN; Bharath RD; Nalini A
    Neuromuscul Disord; 2016 Nov; 26(11):768-774. PubMed ID: 27666775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Muscle MRI in McArdle Disease: A European Multicenter Observational Study.
    Løkken N; Revsbech KL; Jacobsen LN; Martinuzzi A; Martin MÁ; Díaz-Manera J; Dominguez-Gonzalez C; Brondani G; Musumeci O; Granata F; Stefan C; Merino-Sanchez C; Peralta CN; Khawajazada T; Alonso-Pérez J; Toscano A; Vissing J
    Neurology; 2022 Oct; 99(15):e1664-e1675. PubMed ID: 35853747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A founder mutation in Anoctamin 5 is a major cause of limb-girdle muscular dystrophy.
    Hicks D; Sarkozy A; Muelas N; Köehler K; Huebner A; Hudson G; Chinnery PF; Barresi R; Eagle M; Polvikoski T; Bailey G; Miller J; Radunovic A; Hughes PJ; Roberts R; Krause S; Walter MC; Laval SH; Straub V; Lochmüller H; Bushby K
    Brain; 2011 Jan; 134(Pt 1):171-182. PubMed ID: 21186264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical spectrum and gene mutations in a Chinese cohort with anoctaminopathy.
    Cai S; Gao M; Xi J; Liu Z; Yue D; Wu H; Bi H; Li J; Liang Z; Zhao C; Udd B; Luo S; Lu J
    Neuromuscul Disord; 2019 Aug; 29(8):628-633. PubMed ID: 31350120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristic muscle signatures assessed by quantitative MRI in patients with Bethlem myopathy.
    Salim R; Dahlqvist JR; Khawajazada T; Kass K; Revsbech KL; de Stricker Borch J; Munawar Sheikh A; Vissing J
    J Neurol; 2020 Aug; 267(8):2432-2442. PubMed ID: 32363432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequency and characterisation of anoctamin 5 mutations in a cohort of Italian limb-girdle muscular dystrophy patients.
    Magri F; Del Bo R; D'Angelo MG; Sciacco M; Gandossini S; Govoni A; Napoli L; Ciscato P; Fortunato F; Brighina E; Bonato S; Bordoni A; Lucchini V; Corti S; Moggio M; Bresolin N; Comi GP
    Neuromuscul Disord; 2012 Nov; 22(11):934-43. PubMed ID: 22742934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progressive fat replacement of muscle contributes to the disease mechanism of patients with single, large-scale deletions of mitochondrial DNA.
    Hedermann G; Dahlqvist JR; Løkken N; Vissing CR; Knak KL; Andersen LK; Thomsen C; Vissing J
    Neuromuscul Disord; 2018 May; 28(5):408-413. PubMed ID: 29567350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comprehensive study of skeletal muscle imaging in FHL1-related reducing body myopathy.
    Mohassel P; Yun P; Syeda S; Batra A; Bradley AJ; Donkervoort S; Monges S; Cohen JS; Leung DG; Munell F; Ortez C; Sánchez-Montáñez A; Karachunski P; Brandsema J; Medne L; Chaudhry V; Tasca G; Foley AR; Udd B; Arai AE; Walter GA; Bönnemann CG
    Ann Clin Transl Neurol; 2023 Aug; 10(8):1442-1455. PubMed ID: 37483011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of muscular dystrophy in a CRISPR-engineered mutant rabbit model with frame-disrupting ANO5 mutations.
    Sui T; Xu L; Lau YS; Liu D; Liu T; Gao Y; Lai L; Han R; Li Z
    Cell Death Dis; 2018 May; 9(6):609. PubMed ID: 29789544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Muscle MRI in immune-mediated necrotizing myopathy (IMNM): implications for clinical management and treatment strategies.
    Fionda L; Lauletta A; Leonardi L; Perez JA; Morino S; Merlonghi G; Alfieri G; Costanzo R; Tufano L; Vanoli F; Rossini E; Vigo EG; Tartaglione T; Salvetti M; Antonini G; Diaz-Manera J; Garibaldi M
    J Neurol; 2023 Feb; 270(2):960-974. PubMed ID: 36329184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic interest of whole-body MRI in early- and late-onset LAMA2 muscular dystrophies: a large international cohort.
    Quijano-Roy S; Haberlova J; Castiglioni C; Vissing J; Munell F; Rivier F; Stojkovic T; Malfatti E; Gómez García de la Banda M; Tasca G; Costa Comellas L; Benezit A; Amthor H; Dabaj I; Gontijo Camelo C; Laforêt P; Rendu J; Romero NB; Cavassa E; Fattori F; Beroud C; Zídková J; Leboucq N; Løkken N; Sanchez-Montañez Á; Ortega X; Kynčl M; Metay C; Gómez-Andrés D; Carlier RY
    J Neurol; 2022 May; 269(5):2414-2429. PubMed ID: 34559299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of muscle activity just after straight leg raising exercise by using
    Shiozawa H; Ohsawa T; Tsushima Y; Higuchi T; Takagishi K; Chikuda H
    J Orthop Sci; 2018 Mar; 23(2):328-333. PubMed ID: 29287785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lower extremity muscle pathology in myotonic dystrophy type 1 assessed by quantitative MRI.
    Heskamp L; van Nimwegen M; Ploegmakers MJ; Bassez G; Deux JF; Cumming SA; Monckton DG; van Engelen BGM; Heerschap A
    Neurology; 2019 Jun; 92(24):e2803-e2814. PubMed ID: 31118244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anoctamin 5/TMEM16E facilitates muscle precursor cell fusion.
    Whitlock JM; Yu K; Cui YY; Hartzell HC
    J Gen Physiol; 2018 Nov; 150(11):1498-1509. PubMed ID: 30257928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anoctamin 5 (ANO5) muscular dystrophy-three different phenotypes and a new histological pattern.
    Seguí F; Gonzalez-Quereda L; Sanchez A; Matas-García A; Garrabou G; Rodriguez MJ; Gallano P; Grau JM; Milisenda JC
    Neurol Sci; 2020 Oct; 41(10):2967-2971. PubMed ID: 32399949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fatty involution of the gluteus medius muscles: a late-onset girdle myopathy?
    Lassoued S; Laroche M
    Semin Arthritis Rheum; 2011 Dec; 41(3):477-81. PubMed ID: 21592544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MRI of Skeletal Muscles in Participants with Type 2 Diabetes with or without Diabetic Polyneuropathy.
    Stouge A; Khan KS; Kristensen AG; Tankisi H; Schlaffke L; Froeling M; Væggemose M; Andersen H
    Radiology; 2020 Dec; 297(3):608-619. PubMed ID: 33048033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fat fraction distribution in lower limb muscles of patients with CMT1A: A quantitative MRI study.
    Bas J; Ogier AC; Le Troter A; Delmont E; Leporq B; Pini L; Guye M; Parlanti A; Lefebvre MN; Bendahan D; Attarian S
    Neurology; 2020 Apr; 94(14):e1480-e1487. PubMed ID: 31980579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leg muscle involvement in facioscapulohumeral muscular dystrophy assessed by MRI.
    Olsen DB; Gideon P; Jeppesen TD; Vissing J
    J Neurol; 2006 Nov; 253(11):1437-41. PubMed ID: 16773269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.